Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.7%

288 terminated/withdrawn out of 2100 trials

Success Rate

81.8%

-4.7% vs industry average

Late-Stage Pipeline

157 trials in Phase 3/4

Results Transparency

43%

557 of 1291 completed trials have results

Key Signals

292 recruiting557 with results160 terminated128 withdrawn

Enrollment Performance

Analytics

N/A

927(51.4%)

Phase 2

339(18.8%)

Phase 1

270(15.0%)

Early Phase 1

109(6.0%)

Phase 4

79(4.4%)

Phase 3

78(4.3%)

1802Total

N/A(927)

Phase 2(339)

Phase 1(270)

Early Phase 1(109)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2100)

Showing 20 of 2100 trials

NCT04173169Phase 3Completed

Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Role: lead

NCT05377840Not ApplicableCompleted

Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)

Role: lead

NCT07602283Not ApplicableRecruiting

Music for Pain and Dementia

Role: lead

NCT06834217Not ApplicableRecruiting

Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder

Role: lead

NCT03469505Not ApplicableCompleted

Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)

Role: lead

NCT05509166Not ApplicableRecruiting

Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health

Role: lead

NCT04654260Not ApplicableCompleted

Behavior Therapy for Irritability in Autism

Role: lead

NCT07019259Not ApplicableRecruiting

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Role: lead

NCT07125261Phase 1Active Not Recruiting

BHV-7000 Responsive Neurostimulation System (RNS) Study

Role: lead

NCT05313243Phase 2Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Role: lead

NCT06799117Not ApplicableRecruiting

Adaptive Decision Support for Addiction Treatment Master

Role: lead

NCT06312514Not ApplicableWithdrawn

Lafiya HIV-status Neutral Study - Protocol

Role: collaborator

NCT07488819Recruiting

Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974

Role: lead

NCT04495257Phase 1Completed

A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

Role: lead

NCT06002945Completed

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

Role: lead

NCT05518305Recruiting

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

Role: collaborator

NCT06096714Early Phase 1Recruiting

Addictive Threshold of Nicotine

Role: lead

NCT04251416Phase 2Active Not Recruiting

A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

Role: lead

NCT06238323Not ApplicableActive Not Recruiting

Lafiya HIV Self-testing Study Protocol

Role: collaborator

NCT07457567Not ApplicableRecruiting

Neural Mechanisms of the Social Brain

Role: lead